Contact

Write to Us

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Contact Us

    Matrix II, unit 1.10
    Science Park 400
    1098 XH Amsterdam
    The Netherlands

    Email: info@panaxea.eu

    Phone No: +31 20 7400 778

    Follow Us on Twitter

    March 7, 2016
    Health Care Innovations

    Introducing Bert Vrijhoef as our new CIO!

    As of March 2015, we are delighted to welcome Prof. dr. Bert Vrijhoef as the Chief Innovation Officer (CIO) of Panaxea. Dr. Vrijhoef is a renowned international expert in the field of health care innovation and its scientific evaluation. Dr. Vrijhoef: “In my work I continuously strive to detect the […]
    February 17, 2016

    Three take home messages from the Economic Evaluation presentation

    The new Dutch economic evaluation guideline was presented yesterday. Panaxea attended this meeting to be aware of this new guideline, and get familiair with the differences between this guideline and the previous edition. The guideline differs in many aspects from the 2006 version. We compiled a list of three changes […]
    February 10, 2016
    Health Technology Assessment

    The new Dutch economic evaluation guideline

    All parties in health care, from governments to hospitals, are bound to budgets. The use of economic evaluations helps these parties by determining how their budgets can be spend in the most optimal way. However, it is hard for some of these parties to make economic evaluations themselves or to […]
    February 2, 2016

    Panaxea takes place in CRADL consortium

    Panaxea is proud to announce that it takes place in this consortium with 11 other parties, like the Middlesex University and Amsterdam’s Emma Children’s Hospital. CRADL (which stands for Continuous Regional Analysis Device for neonate Lung) will show how EID can provide new cost effective, easy to use, respiratory management […]
    November 9, 2015

    Panaxea posters, presentations and workshops @ISPOR Milan 9-11 November 2015

    Dear ISPORIAN, Panaxea (www.panaxea.eu) provides customized, high-quality analyses about the added value of products and interventions in the care pathway. We specialize in health economic modeling for diagnostica and medical devices to facilitate market access in Europe. Curious to see how tools developed by Panaxea can be used for the […]
    June 3, 2015
    Time-and-motion study

    Articulating the value of diagnostics

    Diagnostics face difficulties in current market conditions to obtain reimbursement and to enter the market efficiently. This white paper highlights the challenges, but more importantly also highlights the opportunities in articulating the value of diagnostics. It is explained why tailored health economic evidence is paramount to show the value of […]
    May 19, 2015

    Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the Netherlands

    Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the Netherlands van Hooijdonk RT1, Steuten LM, Kip MM, Monteban H, Mulder MR, van Braam Houckgeest F, van der Sluijs JP, Abu-Hanna A, Spronk PE, Schultz MJ.
    May 19, 2015
    Cost effective health model

    Generic decision model for diagnostic tests

    To give (potential) clients a preliminary insight in the cost-effectiveness of their diagnostic test, we developed an online generic decision model. This model allows users to compare the cost and effects of a diagnostic test versus not testing by using data they collected themselves, for example data they collected during […]
    May 19, 2015

    Marloes van der Maas joined board “Jong NVTAG”

    Jong NVTAG is a Dutch organization that aims to address the need of young professionals in the field of health economics to meet each other, exchange experiences and learn more about the field. Jong NVTAG does this by organizing multiple events per year, each event centered on one theme that […]